Destruction of Tumor suppressor

Graphic depicts hardwiring, which causes the Mdm2 and bind and opt out of several proteins in cancer.

Credit: Lindsey Mayo, Ph.d., Indiana University School of Medicine

Indiana University School of Medicine and the University of Texas Southwestern and case Western University researchers investigated how colleague protein Mdm2, which is normal, late detection of cancers at an early stage, turn off the gene that prevents the growth of tumours. Conclusion may lead to new drugs, in support of the development of late stage breast cancer and other difficult to treat malignancies.

Researchers have identified the critical pathway, which stimulates the growth of the causes of protein Mdm2 production, which shall bind the most common tumor suppressor p53, as well as the other tumor suppressors and the level of measurement of radio disturbance characteristics of electrical activity in the legal systems of the tumor.The study appears in the January 2010 issue of the journal of Clinical investigation
The principal investigator Lindsey Mayo Ph.d., Herman B Wells Center for Pediatric Research IU School of Medicine and the Indiana University Melvin and Bren Simon Cancer Center member, Associate Professor of Pediatrics, says that keep the Mdm2 not in use, and prevent the destruction of the tumor suppressor Mdm2 objectives, it is essential to prevent the spread of cancer in the body.

Explains the meaning and how Mdm2 recently identified pathways in function, Dr. Mayo used the maximum number of florescent Mdm2 is a Fluorescent light bulb accordingly. "Initially it was only known to have been the light is, how it was enabled. We detected a wall switch and wires that connect the fluorescent light in the test apparatus, having taken into account. "

"This job is an important mechanism to provide new evidence that the tumor cells to promote metastasis. Although it has long been known that tumor suppressor activity triggers the cancer, and information on how these cancer inhibitors are turned on and off is Signaling pathways of the way in which researchers., which will lead to an increase in the Mdm2 it is important to understand the spread of cancer in the body and key attack several late stage cancer," said Dr. Mayo, molecular biochemist, which studies the mechanisms that control the tumor suppressors.

When it is too early to speculate that chemical compounds can produce a successful drug, Dr. Mayo says this new information Mdm2 and its roadmap for new training provides useful compounds that can be bound to prevent protein Mdm2 and finish it attacks the development of tumor suppressors.

Author: Justin234 Source

View the original article here